239 related articles for article (PubMed ID: 18226244)
1. Integration of modeling and simulation into hospital-based decision support systems guiding pediatric pharmacotherapy.
Barrett JS; Mondick JT; Narayan M; Vijayakumar K; Vijayakumar S
BMC Med Inform Decis Mak; 2008 Jan; 8():6. PubMed ID: 18226244
[TBL] [Abstract][Full Text] [Related]
2. Evaluating performance of a decision support system to improve methotrexate pharmacotherapy in children and young adults with cancer.
Dombrowsky E; Jayaraman B; Narayan M; Barrett JS
Ther Drug Monit; 2011 Feb; 33(1):99-107. PubMed ID: 21192315
[TBL] [Abstract][Full Text] [Related]
3. Strategies for pharmacy integration and pharmacy information system interfaces, Part 1: History and pharmacy integration options.
Chaffee BW; Bonasso J
Am J Health Syst Pharm; 2004 Mar; 61(5):502-6. PubMed ID: 15018229
[No Abstract] [Full Text] [Related]
4. MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase.
Taylor ZL; Mizuno T; Punt NC; Baskaran B; Navarro Sainz A; Shuman W; Felicelli N; Vinks AA; Heldrup J; Ramsey LB
Clin Pharmacol Ther; 2020 Sep; 108(3):635-643. PubMed ID: 32558929
[TBL] [Abstract][Full Text] [Related]
5. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
Dupuis C; Mercier C; Yang C; Monjanel-Mouterde S; Ciccolini J; Fanciullino R; Pourroy B; Deville JL; Duffaud F; Bagarry-Liegey D; Durand A; Iliadis A; Favre R
Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia.
Aumente D; Buelga DS; Lukas JC; Gomez P; Torres A; García MJ
Clin Pharmacokinet; 2006; 45(12):1227-38. PubMed ID: 17112298
[TBL] [Abstract][Full Text] [Related]
7. Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer.
Monjanel-Mouterde S; Lejeune C; Ciccolini J; Merite N; Hadjaj D; Bonnier P; Piana P; Durand A
J Clin Pharm Ther; 2002 Jun; 27(3):189-95. PubMed ID: 12081632
[TBL] [Abstract][Full Text] [Related]
8. Optimization of drug-drug interaction alert rules in a pediatric hospital's electronic health record system using a visual analytics dashboard.
Simpao AF; Ahumada LM; Desai BR; Bonafide CP; Gálvez JA; Rehman MA; Jawad AF; Palma KL; Shelov ED
J Am Med Inform Assoc; 2015 Mar; 22(2):361-9. PubMed ID: 25318641
[TBL] [Abstract][Full Text] [Related]
9. Bayesian-based diagnostic decision-support for pediatrics.
Pyper C; Frize M; Lindgaard G
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():4318-21. PubMed ID: 19163668
[TBL] [Abstract][Full Text] [Related]
10. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
Fukuhara K; Ikawa K; Morikawa N; Kumagai K
J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
[TBL] [Abstract][Full Text] [Related]
12. Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma.
Rousseau A; Sabot C; Delepine N; Delepine G; Debord J; Lachâtre G; Marquet P
Clin Pharmacokinet; 2002; 41(13):1095-104. PubMed ID: 12403645
[TBL] [Abstract][Full Text] [Related]
13. Key performance indicators for the assessment of pediatric pharmacotherapeutic guidance.
Barrett JS; Patel D; Jayaraman B; Narayan M; Zuppa A
J Pediatr Pharmacol Ther; 2008 Jul; 13(3):141-55. PubMed ID: 23055875
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma.
Colom H; Farré R; Soy D; Peraire C; Cendros JM; Pardo N; Torrent M; Domenech J; Mangues MA
Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931
[TBL] [Abstract][Full Text] [Related]
15. Pharmacy informatics in multihospital health systems: Opportunities and challenges.
Chalmers J; Siska M; Le T; Knoer S
Am J Health Syst Pharm; 2018 Apr; 75(7):457-464. PubMed ID: 29572314
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetic analysis of high-dose methotrexate in pediatric and adult oncology patients.
Kawakatsu S; Nikanjam M; Lin M; Le S; Saunders I; Kuo DJ; Capparelli EV
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1339-1348. PubMed ID: 31586225
[TBL] [Abstract][Full Text] [Related]
17. Implementing computerized prescriber order entry in a children's hospital.
Jones JL
Am J Health Syst Pharm; 2004 Nov; 61(22):2425-9. PubMed ID: 15581267
[No Abstract] [Full Text] [Related]
18. [Therapeutic drug monitoring of methotrexate after its administration in high-dose protocols].
Le Guellec C; Blasco H; Benz I; Hulin A;
Therapie; 2010; 65(3):163-9. PubMed ID: 20699066
[TBL] [Abstract][Full Text] [Related]
19. Decision support from local data: creating adaptive order menus from past clinician behavior.
Klann JG; Szolovits P; Downs SM; Schadow G
J Biomed Inform; 2014 Apr; 48():84-93. PubMed ID: 24355978
[TBL] [Abstract][Full Text] [Related]
20. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
